
|Articles|March 20, 2023
Phlexglobal Announces Availability of New eTMF AI
Advertisement
Phlexglobal has announced the general availability of PhlexTMF v21: an eTMF solution with artificial intelligence. Organizations can utilize PhlexTMF v21 to reduce TMF document misfiles and metadata errors—improving TMF quality, completeness, and timeliness.
PhlexTMF v21 immediately enables new as well as experienced document submitters to:
- Improve TMF quality and reduce inspection risk
- Increase the speed and accuracy of document submissions
- Focus on bringing TMF best practices around quality, completeness, and timeliness into the process earlier
Reference
Phlexglobal Announces Industry-First eTMF AI that Reduces Risk of Document Misfiles and Metadata Errors to Improve TMF Quality and Inspection-Readiness. (2023, March 20). Phlexglobal.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
3
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
4
A Shot in the Arm to Traditional Vaccine Trial Strategy
5




